Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Findings provide new insights into the basic biology of stem cells

A team of researchers from the University of California, San Diego School of Medicine, Oregon Health & Science University and Salk Institute for Biological Studies has shown for the first time that stem cells created using different methods produce differing cells.

3 Jul 2014

Regular walking may ease Parkinson's symptoms

People with mild to moderate Parkinson's disease who regularly walk for exercise may improve their motor function, mood, tiredness, fitness and some aspects of thinking abilities, according to a study published in the July 2, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

3 Jul 2014

Use of NMR in diagnostic research: an interview with Elaine Holmes, Imperial College

The Phenome Center developed out of the Olympic drug testing facility, and we've adapted it so that we use NMR spectrometry, which we have three spectrometers, and mass spectrometry, to take blood and urine from hundreds and thousands of people and profile them to get a biochemical fingerprint of every person.

From Bruker BioSpin Group 1 Jul 2014

New Tel Aviv University study finds link between Alzheimer's and brain hyperactivity

Patients with Alzheimer's disease run a high risk of seizures. While the amyloid-beta protein involved in the development and progression of Alzheimer's seems the most likely cause for this neuronal hyperactivity, how and why this elevated activity takes place hasn't yet been explained - until now.

1 Jul 2014

EMA CHMP recommends marketing authorization for GE's VIZAMYL for PET imaging to detect beta amyloids

GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use. This opinion recommends the granting of a marketing authorisation for VIZAMYL (Flutemetamol F18 injection), a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive impairment.

30 Jun 2014

Newly identified compound may halt progression of Alzheimer's disease

Without a steady supply of blood, neurons can't work. That's why one of the culprits behind Alzheimer's disease is believed to be the persistent blood clots that often form in the brains of Alzheimer's patients, contributing to the condition's hallmark memory loss, confusion and cognitive decline.

28 Jun 2014

Researchers give new, unprecedented 3-D view of most important brain receptors

Researchers with Oregon Health & Science University's Vollum Institute have given science a new and unprecedented 3-D view of one of the most important receptors in the brain - a receptor that allows us to learn and remember, and whose dysfunction is involved in a wide range of neurological diseases and conditions, including Alzheimer's, Parkinson's, schizophrenia and depression.

28 Jun 2014

Public health issues: Climate change; funding for Alzheimer's research

A medical expert calls for hospitals and health care officials to begin to plan for global warming problems, and The Wall Street Journal looks at new ways to finance research.

27 Jun 2014

Blocking enzyme Cdk5 could reduce brain damage after stroke

A drug that blocks the action of the enzyme Cdk5 could substantially reduce brain damage if administered shortly after a stroke, UT Southwestern Medical Center research suggests.

27 Jun 2014

Veterans with traumatic brain injury more likely to develop dementia in later life

Older veterans who have experienced a traumatic brain injury (TBI) are 60 percent more likely to later develop dementia than veterans without TBI, according to a study published in the June 25, 2014, online issue of Neurology, the medical journal of the American Academy of Neurology.

25 Jun 2014

Research finding could open new opportunities for treating Huntington's disease

Researchers believe they have learned how mutations in the gene that causes Huntington's disease kill brain cells, a finding that could open new opportunities for treating the fatal disorder. Scientists first linked the gene to the inherited disease more than 20 years ago

24 Jun 2014

Cocoa-extract may reduce damage to nerve pathways in Alzheimer's patients' brains

A specific preparation of cocoa-extract called Lavado may reduce damage to nerve pathways seen in Alzheimer's disease patients' brains long before they develop symptoms, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published June 20 in the Journal of Alzheimer's Disease (JAD).

24 Jun 2014

Study reveals that inflammasomes remain active even after cell death

Even after a cell dies, components of the immune system remain active and continue to fuel inflammatory reactions.

23 Jun 2014

Long-term care for soaring numbers of people with dementia need to be improved, says new RAND study

As millions of Americans struggle to help loved ones with dementia, policymakers should consider more ways to improve long-term services and supports for the soaring numbers of people with the debilitating condition and their caregivers, a new RAND Corporation study says -- and it offers possible ways to do so.

23 Jun 2014

LBDA offers condolences over death of LBD patient

The sad news of Casey Kasem's illness and passing has brought unexpected visibility to a disease unfamiliar to many people.

20 Jun 2014

59% of people believe that Alzheimer's is a typical part of aging

Alzheimer's is a fatal, progressive disease impacting at least 44 million people worldwide yet it is widely misunderstood. According to an Alzheimer's Association® 12-country survey, 59 percent of people surveyed incorrectly believe that Alzheimer's disease is a typical part of aging and 40 percent of people believe that Alzheimer's is not fatal.

19 Jun 2014

Self-repairing mechanism of adult brain can help preserve brain function in Alzheimer's

New research, led by scientists at the University of Southampton, has found that neurogenesis, the self-repairing mechanism of the adult brain, can help to preserve brain function in neurodegenerative diseases such as Alzheimer's, Prion or Parkinson's.

19 Jun 2014

People with muscle diseases may benefit more from group doctor visits

A new study suggests that people with muscle diseases such as muscular dystrophies may benefit more from group doctor visits than individual appointments. The study is published in the June 18, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

19 Jun 2014

Researchers explore role of stem cells in treating neuroinjury and neurodegenerative disorders

Researchers at the University of Florida, USA, led by Dr. K. Wang have demonstrated that inhibition of Rho-associated kinase (ROCK) and subsequent cofilin dephosphorylation is mediating neurite outgrowth in PC12 cells.

18 Jun 2014

New investigational drug can slow memory loss in older Individuals with risk for developing AD in future

A new research study at Rush University Medical Center and Northwestern Medicine is testing whether a new investigational treatment can slow the memory loss caused by Alzheimer's disease.

17 Jun 2014

Alzheimer's Disease News and Research

Further Reading

Findings provide new insights into the basic biology of stem cells

Regular walking may ease Parkinson's symptoms

Use of NMR in diagnostic research: an interview with Elaine Holmes, Imperial College

New Tel Aviv University study finds link between Alzheimer's and brain hyperactivity

EMA CHMP recommends marketing authorization for GE's VIZAMYL for PET imaging to detect beta amyloids

Newly identified compound may halt progression of Alzheimer's disease

Researchers give new, unprecedented 3-D view of most important brain receptors

Public health issues: Climate change; funding for Alzheimer's research

Blocking enzyme Cdk5 could reduce brain damage after stroke

Veterans with traumatic brain injury more likely to develop dementia in later life

Research finding could open new opportunities for treating Huntington's disease

Cocoa-extract may reduce damage to nerve pathways in Alzheimer's patients' brains

Study reveals that inflammasomes remain active even after cell death

Long-term care for soaring numbers of people with dementia need to be improved, says new RAND study

LBDA offers condolences over death of LBD patient

59% of people believe that Alzheimer's is a typical part of aging

Self-repairing mechanism of adult brain can help preserve brain function in Alzheimer's

People with muscle diseases may benefit more from group doctor visits

Researchers explore role of stem cells in treating neuroinjury and neurodegenerative disorders

New investigational drug can slow memory loss in older Individuals with risk for developing AD in future

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News